ARCHIVES

Enzalutamide Reduced Risk of Progression By 81 Percent in Metastatic Prostate Cancer

This article is from The Cancer Letter archive.

Vol. 37 No. 6 | June 27, 2014

Download PDF Visit The Full Archive

Related Articles

Kennedy, Hutchison Introduce Long-Awaited Bill To Reauthorize The National Cancer Program

April 3, 2009

Phase II Study: Proton Therapy Can Have Similar Success Rate, Smaller Level of Risk in Treatment of Hodgkin Lymphoma

July 25, 2014

Cancer Cases To Double By 2050 As U.S. Population Ages, Annual Report Says.

May 17, 2002

NCI Plans $175 Million In Program Cuts To Cover Deficit, Fund New Initiatives

November 17, 2006

In Brief: Deadline June 1 For Cancer Research Institute Grants; Chabner To Present Karnofsky Lecture

May 3, 1985

NCAB Supports ACS Effort To Work With Centers

March 1, 1991